Capital Cs Group, LLC Tg Therapeutics, Inc. Transaction History
Capital Cs Group, LLC
- $213 Million
- Q1 2024
A detailed history of Capital Cs Group, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Capital Cs Group, LLC holds 17,525 shares of TGTX stock, worth $348,922. This represents 0.12% of its overall portfolio holdings.
Number of Shares
17,525
Previous 17,525
-0.0%
Holding current value
$348,922
Previous $299,000
11.04%
% of portfolio
0.12%
Previous 0.14%
Shares
3 transactions
Others Institutions Holding TGTX
# of Institutions
269Shares Held
87.7MCall Options Held
2.72MPut Options Held
1.74M-
Vanguard Group Inc Valley Forge, PA13.5MShares$270 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.8MShares$216 Million0.0% of portfolio
-
State Street Corp Boston, MA7.8MShares$155 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.48MShares$69.4 Million0.02% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.33MShares$66.2 Million0.06% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $2.89B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...